129 related articles for article (PubMed ID: 11129585)
1. Characterization of human recombinant transglutaminase 1 purified from baculovirus-infected insect cells.
Hitomi K; Yamagiwa Y; Ikura K; Yamanishi K; Maki M
Biosci Biotechnol Biochem; 2000 Oct; 64(10):2128-37. PubMed ID: 11129585
[TBL] [Abstract][Full Text] [Related]
2. Characterization of recombinant mouse epidermal-type transglutaminase (TGase 3): regulation of its activity by proteolysis and guanine nucleotides.
Hitomi K; Kanehiro S; Ikura K; Maki M
J Biochem; 1999 Jun; 125(6):1048-54. PubMed ID: 10348906
[TBL] [Abstract][Full Text] [Related]
3. Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase.
Lai TS; Hausladen A; Slaughter TF; Eu JP; Stamler JS; Greenberg CS
Biochemistry; 2001 Apr; 40(16):4904-10. PubMed ID: 11305905
[TBL] [Abstract][Full Text] [Related]
4. Overproduction of soluble recombinant transglutaminase from Streptomyces netropsis in Escherichia coli.
Yu YJ; Wu SC; Chan HH; Chen YC; Chen ZY; Yang MT
Appl Microbiol Biotechnol; 2008 Dec; 81(3):523-32. PubMed ID: 18810430
[TBL] [Abstract][Full Text] [Related]
5. The core domain of the tissue transglutaminase Gh hydrolyzes GTP and ATP.
Iismaa SE; Chung L; Wu MJ; Teller DC; Yee VC; Graham RM
Biochemistry; 1997 Sep; 36(39):11655-64. PubMed ID: 9305955
[TBL] [Abstract][Full Text] [Related]
6. Sphingosylphosphocholine reduces the calcium ion requirement for activating tissue transglutaminase.
Lai TS; Bielawska A; Peoples KA; Hannun YA; Greenberg CS
J Biol Chem; 1997 Jun; 272(26):16295-300. PubMed ID: 9195933
[TBL] [Abstract][Full Text] [Related]
7. GTP, an inhibitor of transglutaminases, is hydrolyzed by tissue-type transglutaminase (TGase 2) but not by epidermal-type transglutaminase (TGase 3).
Hitomi K; Ikura K; Maki M
Biosci Biotechnol Biochem; 2000 Mar; 64(3):657-9. PubMed ID: 10803976
[TBL] [Abstract][Full Text] [Related]
8. GTP hydrolysis by human tissue transglutaminase homologue.
Fraij BM
Biochem Biophys Res Commun; 1996 Jan; 218(1):45-9. PubMed ID: 8573173
[TBL] [Abstract][Full Text] [Related]
9. Analysis of epidermal-type transglutaminase (transglutaminase 3) in human stratified epithelia and cultured keratinocytes using monoclonal antibodies.
Hitomi K; Presland RB; Nakayama T; Fleckman P; Dale BA; Maki M
J Dermatol Sci; 2003 Aug; 32(2):95-103. PubMed ID: 12850301
[TBL] [Abstract][Full Text] [Related]
10. Purification and characterization of rat brain transglutaminase.
Ohashi H; Itoh Y; Birckbichler PJ; Takeuchi Y
J Biochem; 1995 Dec; 118(6):1271-8. PubMed ID: 8720146
[TBL] [Abstract][Full Text] [Related]
11. Sphingosylphosphorylcholine is an activator of transglutaminase activity in human keratinocytes.
Higuchi K; Kawashima M; Takagi Y; Kondo H; Yada Y; Ichikawa Y; Imokawa G
J Lipid Res; 2001 Oct; 42(10):1562-70. PubMed ID: 11590211
[TBL] [Abstract][Full Text] [Related]
12. Calpain inhibitors reduce the cornified cell envelope formation by inhibiting proteolytic processing of transglutaminase 1.
Kim SY; Bae CD
Exp Mol Med; 1998 Dec; 30(4):257-62. PubMed ID: 9894158
[TBL] [Abstract][Full Text] [Related]
13. Purification and characterization of the active-site-mutated recombinant human mu-calpain expressed in baculovirus-infected insect cells.
Hitomi K; Uchiyama Y; Ohkubo I; Kunimatsu M; Sasaki M; Maki M
Biochem Biophys Res Commun; 1998 May; 246(3):681-5. PubMed ID: 9618272
[TBL] [Abstract][Full Text] [Related]
14. GTP is required to stabilize and display transamidation activity of transglutaminase 2.
Jeon JH; Cho SY; Kim CW; Shin DM; Kweon JC; Choi KH; Park SC; Kim IG
Biochem Biophys Res Commun; 2002 Jun; 294(4):818-22. PubMed ID: 12061780
[TBL] [Abstract][Full Text] [Related]
15. Biochemical properties of lens-specific calpain Lp85.
Shih M; Ma H; Nakajima E; David LL; Azuma M; Shearer TR
Exp Eye Res; 2006 Jan; 82(1):146-52. PubMed ID: 16054132
[TBL] [Abstract][Full Text] [Related]
16. Crystallization and preliminary X-ray analysis of human transglutaminase 3 from zymogen to active form.
Kim HC; Nemes Z; Idler WW; Hyde CC; Steinert PM; Ahvazi B
J Struct Biol; 2001 Jul; 135(1):73-7. PubMed ID: 11562168
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a transglutaminase expressed in human pancreatic adenocarcinoma cells.
Elsässer HP; MacDonald R; Dienst M; Kern HF
Eur J Cell Biol; 1993 Aug; 61(2):321-8. PubMed ID: 7901019
[TBL] [Abstract][Full Text] [Related]
18. Purification and on-column activation of a recombinant histidine-tagged pro-transglutaminase after soluble expression in Escherichia coli.
Yang HL; Pan L; Lin Y
Biosci Biotechnol Biochem; 2009 Nov; 73(11):2531-4. PubMed ID: 19897898
[TBL] [Abstract][Full Text] [Related]
19. Calreticulin down-regulates both GTP binding and transglutaminase activities of transglutaminase II.
Feng JF; Readon M; Yadav SP; Im MJ
Biochemistry; 1999 Aug; 38(33):10743-9. PubMed ID: 10451369
[TBL] [Abstract][Full Text] [Related]
20. Kinetic analysis of the interaction of tissue transglutaminase with a nonpeptidic slow-binding inhibitor.
Case A; Stein RL
Biochemistry; 2007 Jan; 46(4):1106-15. PubMed ID: 17240993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
